Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: A single center experience-Reference-Cited by-同舟云学术

Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: A single center experience

Published:2011-07 Issue:1 Volume:79 Page:31-42
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Stratta Piero,Gravellone Luciana,Cena Tiziana,Rossi Davide,Gaidano GianLuca,Fenoglio Roberta,Lazzarich Elisa,Quaglia Marco,Airoldi Andrea,Bozzola Cristina,Monga Guido,Valente Guido,Canavese Caterina,Magnani Corrado

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference52 articles.

1. Ominous consequences of immunoglobulin deposition;Solomon;N Engl J Med,1993

2. Abnormal immunoglobulin synthesis in monoclonal light chain and light and heavy chain deposition disease;Buxbaum;Amyloid,2001

3. Dangerous small B-cell clones;Merlini;Blood,2006

4. Immunoglobulin light (heavy) chain deposition disease: from molecular medicine to pathophysiology-driven therapy;Ronco;Clin J Am Soc Nephrol,2006

5. Renal manifestations of plasma cell dyscrasias: an appraisal from the patients’ bedside to the research laboratory;Herrera;Ann Diagn Pathol,2000

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 5th edition of the World Health Organization Classification of mature lymphoid and stromal tumors – an overview and update;Leukemia & Lymphoma;2024-01-08

2. Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach;American Journal of Hematology;2023-01

4. Light Chain Restriction in Proximal Tubules—Implications for Light Chain Proximal Tubulopathy;Frontiers in Medicine;2022-03-28

5. Low dose stereotactic irradiation and dexamethasone in primary cerebral light chain deposition disease (LCDD);Leukemia & Lymphoma;2021-03-31